UK coronavirus cases continue to decline with 28,680 more positive tests in 24% drop from last Thursday as another 1,239 Covid deaths are confirmed
- Cases have been down week-on-week every day for 20 days in a row, the latest data from Health chiefs shows
- Death toll remains high as almost 37,000 patients are still receiving treatment in hospitals across the UK
- Separate data shows lockdown 3.0 is bringing winter outbreak under control, although some say it is too slow
Britain today confirmed another 28,680 cases of coronavirus in another week-on-week drop, with 24 per cent fewer than last Thursday.
The number, although slightly higher than yesterday, is another sign that the third national lockdown in England is working and infections are coming under control.
The Department of Health also announced another 1,239 people had died with the virus, taking the total to 103,126.
This was a small decline on this time last week – four per cent – and this figure will be the slowest to fall in the wake of infection numbers and hospital inpatients.
It comes as separate Public Health England figures show that the rates of positive tests tumbled in 97 per cent of all the country’s local authorities last week.
Those rates also fell in every region of England and in all age groups.
And NHS Test & Trace data saw a 17 per cent decline in the weekly total number of people testing positive, to 275,000 from 330,000 a week earlier.
Boris Johnson met armed forces personnel at a youth centre in Castlemilk, Glasgow today, as he thanked people for their efforts on the coronavirus response
Nicola Sturgeon was accused of taking the EU’s side in the bitter vaccine row today as she vowed to publish details of the UK’s supplies despite Boris Johnson ordering her to keep them secret.
In an extraordinary move, the First Minister risked undermining Britain’s position, with Brussels heaping pressure on firms to give the bloc a bigger share of the stocks.
Despite the PM warning that the information must be confidential to protect the rollout, Ms Sturgeon told Holyrood she will release it from next week ‘regardless of what they say’.
Tory MPs vented fury at Ms Sturgeon – who wants Scotland to go independent and rejoin the bloc – over the intervention, saying she is ‘obviously more inclined to help the EU than she is the UK’.
The row erupted as tensions between the EU and UK over vaccine supplies escalated again, with MEPs threatening ‘trade war’.
There are claims officials have been sent from the medicines agency to the AstraZeneca plant in Belgium to check it genuinely has problems producing doses.
It comes as the bloc tries to turn the screw on the UK-based pharma giant to bail out its shambolic vaccine rollout. European politicians warned the ‘consequences’ of refusing to divert stocks of the UK-made jabs to EU would be a ban on exports of the Pfizer version from Belgium – suggesting 3.5million doses due to arrive soon could be at risk.
EU chiefs want more of the Oxford jabs – made in Staffordshire and Oxfordshire – be handed over to make up for a 75million shortfall on the continent.
The European Commission said the Anglo-Swedish firm was obliged to meet its contractual obligations despite production issues at its Belgian site.
So far both AstraZeneca and Pfizer look to be holding firm against the sabre-rattling from Brussels.
It comes after MEPs warned that the UK would ‘suffer’ for denying the EU, and the bloc’s health commissioner insisted Britain should not receive priority – even though it signed a contract with AstraZeneca three months before Brussels did.
Stella Kyriakides said: ‘We reject the logic of first come, first served. That may work in a butcher’s shop but not in contracts and not in our advanced purchase agreements.’
Cabinet minister Michael Gove said the UK will discuss ‘how we can help’ the EU’s vaccination effort. But asked if the UK might lose out because the EU has not got enough doses, Mr Gove said: ‘No. The programme of vaccination has been agreed and assured and the supplies were fixed some time ago and we will make sure that the vaccine programme proceeds exactly as planned.’
He told ITV’s Good Morning Britain: ‘Of course it is the case that we will want to talk with our friends in Europe to see how we can help, but the really important thing is making sure that our own vaccination programme proceeds precisely as planned.’
It comes as in another day of coronavirus news:
- Boris Johnson and UK health chiefs insist Oxford/AstraZeneca Covid vaccine dose work after Germany says it should not be used for over-65s due to ‘insufficient data’;
- Parents call for pupils to be allowed to repeat a whole year of schooling lost due to the pandemic;
- Scientist warns a new ‘Disease X’ outbreak could be just ‘around the corner’ and the next pandemic is only a matter of ‘when’;
- Prime Minister defends trip to Scotland to shore-up the union after he was reported to police by nationalists;
- Number of people testing positive for the virus in England falls 17 per cent in a week with 275,000 cases in seven days to January 20 – the lowest number since before Christmas;
- Covid-denying conspiracy theorist, 46, dies from the virus after refusing to wear a mask and follow social distancing rules;
- Cases of Covid-19 caught in hospitals have fallen by a third since the start of January, data shows;
It comes after Boris Johnson, UK health chiefs and AstraZeneca all insisted their coronavirus vaccine does work in all age groups after German authorities said it should not be used in over-65s due to ‘insufficient data’.
The PM and Public Health England struck a bullish note after a Berlin commission said there was ‘insufficient data to assess the efficacy of the vaccine for persons aged 65 years and older’.
British regulators, by contrast, have approved the jab for all age groups – with AstraZeneca pointing to data published in a medical journal showing that 100 per cent of older adults generated antibodies in trials.
Germany’s stance comes amid an angry row between the EU and AstraZeneca over vaccine supplies, with the bloc lagging far behind Britain in immunising its population against Covid-19.
Although it is possible the position could change with more evidence, it raises the prospect of splits between the UK and EU on what vaccines are regarded as effective – with speculation that in the future travel to some destinations could be contingent on having been inoculated.
On a visit to Scotland this afternoon, Mr Johnson said he was not worried about the news from Germany. ‘No, because the MHRA (Medicines and Healthcare products Regulatory Agency) our own authorities have made it very clear that they think the Oxford-AstraZeneca is very good and efficacious and gives a high degree of protection after just one does and even more after two doses,’ he said.
The PM said the MHRA concluded the vaccine is ‘effective across all age groups’ and ‘provides a good immune response across all age groups’. He added on the German conclusions: ‘So I don’t agree with that.’
Dr Mary Ramsay, head of immunisations at PHE, said there had been ‘too few cases’ of coronavirus in older people in Phase 3 clinical trial to determine efficacy in this age group, but other data on immune response had been ‘reassuring’.
AstraZeneca said: ‘The latest analyses of clinical trial data for the AstraZeneca/Oxford Covid-19 vaccine support efficacy in the over 65 years age group.’
The German panel did not endorse the sensational claim published by German media on Monday that the jab is only eight per cent effective among over-65s, a theory debunked by the manufacturers and the German health ministry.
Instead, it said there was not enough data to make a decision either way – after AstraZeneca’s boss said the ‘very ethical’ Oxford scientists had slowed down trials on older people until the vaccine was proved to be safe.
It remains to be seen whether the European Medicines Agency will make a similar determination on Friday, after EMA chief Emer Cooke said on Tuesday that the body could decide to split hairs between age groups.
Meanwhile, the brutal row over stocks is raging, with the EU demanding AstraZeneca make up for delays by supplying doses from its UK factories. Mr Johnson said he expects the British-Swedish firm to continue providing two million doses a week to the UK.
Dr Ramsay said: ‘Both the AstraZeneca and Pfizer/BioNTech vaccines are safe and provide high levels of protection against Covid-19, particularly against severe disease.
‘There were too few cases in older people in the AstraZeneca trials to observe precise levels of protection in this group, but data on immune responses were very reassuring.
‘The risk of severe disease and death increase exponentially with age – the priority is to vaccinate as many vulnerable people as possible with either vaccine, to protect more people and save more lives.’
The UK is one of the world’s leading countries when it comes to the speed of the roll-out of its coronavirus vaccination programme – a fact made all the more impressive given where the nation started when the pandemic hit early last year.
At that point the country had just one vaccine manufacturing site – a facility in Liverpool which made flu jabs.
But the Government quickly set up a vaccine task force in April to make sure the UK was well-positioned to benefit from medical breakthroughs.
The experts appointed to the task force reportedly recommended seven projects for investment within its first two weeks, according to The Times.
Advance purchase orders were hammered out by the task force with suppliers despite the fact there were no guarantees that any of the vaccines would work or that they would be signed off by regulators.
That early work meant the UK was in pole position to receive the jabs, if and when they were shown to be effective and safe.
The task force’s strategy means two companies have been relied upon to do much of the heavy lifting during the UK’s vaccine roll-out: Pfizer and AstraZeneca.
The UK ordered 40 million doses from the former and 100 million doses from the latter.
Coronavirus cases in England have fallen 17 per cent in a week amid brutal lockdown restrictions, official figures reveal.
Test and Trace said 274,898 people tested positive for the virus in the week to January 20, the lowest number since before Christmas and the second week in a row a dip has been recorded.
It is another glimmer of hope that measures are turning the tide on the second wave after separate statistics from a Government-commissioned study also showed cases were dipping in England – although scientists insisted the drop was ‘shallow’.
And Department of Health figures are indicating the number of Britons testing positive for the virus every day is falling – with yesterday’s figures 88 per cent below the levels two weeks ago.
Experts say lockdown is reducing transmission of the virus, although some worry this isn’t happening fast enough to relieve pressure on over-stretched hospitals.
Test and Trace – run by the Department of Health and private contracters – has been dogged by allegations it is too slow to reach positive cases and had failed to plan ahead for spiking numbers of infections in September when schools returned.
The figures published today show almost 56,000 fewer Britons tested positive for the virus in the third week of January than the week before.
There were 330,871 positive swabs in this week, which was 57,000 people fewer than the seven-day spell before when 388,037 people tested positive – the peak of the second wave.
Test and Trace figures only pick up symptomatic cases – when someone gets a swab after suffering a high temperature, new continuous cough or loss of taste and smell.
But they leave out those that are infected but are not experiencing any symptoms of the virus.
The Health Minister Lord Bethell today warned one in three people who are infected with the virus do not suffer symptoms, ‘meaning you can infect others unknowingly’.
‘It is therefore crucial that we continue to follow public health guidance, and all play our part by following the rules and reducing our social contact to slow the spread of the virus,’ he said.
The above graph shows the number of people testing positive for the virus. The dark blue bar shows those who tested positive under pillar 2 – tests carried out in the community – and the light blue represents those who tested positive under pillar 1 – swabs in hospitals
Mr Matthews, who exercised regularly, is understood to have told a local conspiracy theorist that he suffered from asthma – though his family said they were not aware of his condition and suggested he may have kept an inhaler on him to exempt himself from wearing a mask
A Covid-denying conspiracy theorist who refused to wear a face mask died a day after testing positive for the virus.
Gary Matthews, 46, had been ill for around a week before testing positive for coronavirus on January 12. He died alone in his flat in Shrewsbury, Shropshire the next evening, according to the Guardian.
Mr Matthews, who exercised regularly, is understood to have told a local conspiracy theorist that he suffered from asthma – though his family said they were not aware of his condition and suggested he may have kept an inhaler on him to exempt himself from wearing a mask.
His heartbroken family insist that he did not believe Covid-19 was real, and would not adhere to government pandemic measures including social distancing and mask mandates.
Conspiracy theorists claim Mr Matthews may have killed himself, and have bandied about the outlandish suggestion that he was ‘murdered’ by the state, the Guardian reports. However, an autopsy has not taken place.
Britain has recorded more than 100,000 Covid-related deaths, with scientists claiming the victims could have been reduced if the government had taken tougher action earlier in the pandemic.
Mr Matthews’ cousin Tristan Copeland said he had begged him to wear a mask and maintain social distance.
‘But he and his friends had the mindset that they needed to go out and meet people to show they didn’t believe the government,’ he said.
He called Mr Matthews ‘quite shy’ and was ‘led astray’ by conspiracy theorists he found on Facebook groups.
‘I think these groups gave him that. He was ripe to be adopted into it and they led him astray,’ Mr Copeland said.
‘About two or three years ago he became very concerned about the conflict in Syria from a humanitarian point of view. I think he read a few stories which led him to distrust the media. Eventually that led him to some climate change denial groups which he started posting on.’
The data shows the average number of Covid-19 cases caught on wards has dropped from 553 on January 10 to an average low of 369 on January 25 across England
Cases of coronavirus caught on hospital wards have fallen by a third since the start of January despite a record number of inpatients, NHS figures show.
The data shows the average number of Covid-19 cases caught on wards in England has dropped from 553 on January 10 to 369 on January 25, a fall of 33 per cent.
This has happened despite the number of patients in hospitals rising throughout the month, with a now record 3,600 people in intensive care and 32,000 inpatients.
Falling in-hospital infections, also known as nosocomial infections, come alongside a decline in daily hospital admissions in all regions of England.
The number of Covid cases caught in hospital on any single day this month was highest on January 4 with 635 cases, a day before the third national lockdown came into force.
This then halved to a low of 304 on January 22, while the daily average, calculated over seven days, has declined more slowly.
The total number of Covid-19 patients on wards remains ‘incredibly high’, Professor Chris Whitty warned this week, and is 80 per cent above the peak of the first wave.
And the numbers on mechanical ventilators are at their highest level since the pandemic began at 30 per cent above the levels in April, although in the most recent days this has started to dip on a national level.
Preventing the spread of coronavirus in hospital is being achieved by all patient-facing staff wearing large amounts of protective equipment.
All are required to wear gloves, masks and aprons whether they are meeting Covid patients or not.
And wards have been segregated to keep Covid-positive patients away from others who are there for treatment for other serious illnesses.
The risk of transmission in hospitals is high because patients generally have large amounts of the virus in their body, which is what makes them sicker, and medical staff regularly have to touch them and get extremely close.
Testing surveys have found that staff working in patient-facing medical roles are more likely to contract coronavirus than the general population.
But hospitals are now warning that keeping Covid and non-Covid patients separate is becoming increasingly
Source: Read Full Article